An evaluation of antimicrobial treatment for whipple's disease
Authors:
- 1 August 1994
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 39 (8) , 1642-1648
Abstract
Whipple's disease is a multisystemic disorder in which almost all organ systems can be invaded by rod-shaped bacteria. Without extended antimicrobial therapy, its course is lethal. Empirically, treatment consists of tetracyclines given for one to two years. Trimethoprim-sulfamethoxazole, a compound that crosses the blood-brain barrier, has been suggested as an alternative when patients were observed with progressive cerebral involvement. There has never been a formal evaluation of the selection of antibiotics for the treatment of Whipple's disease. In the present nonrandomized, partially retrospective study, we compared the result of two treatment regimens in 30 patients, all examined personally. Twenty-two patients were treated with tetracycline and eight patients with trimethoprim-sulfamethoxazole. In five patients, therapy with tetracycline was changed to another antimicrobial agent because of treatment failure or drug intolerance. The main treatment measure was disappearance of the clinical symptoms such as weight loss, arthritis, malabsorption, fever, edema, central nervous system manifestations, lymphadenopathy, and congestive heart failure. Drug intolerance requiring a change of medication was also considered a treatment failure. We found that trimethoprim-sulfamethoxazole induced complete clinical remission in 12 of 13 treatment cycles, tetracycline in 13 of 22 treatment cycles (P<0.05; mean difference 33%; 95% confidence interval 8% to 58%). Trimethoprim-sulfamethoxazole was also more efficacious than tetracycline in the treatment of cerebral Whipple's disease. However, trimethoprim-sulfamethoxazole did not prevent cerebral manifestations in all cases. The only deaths due to Whipple's disease occurred in patients with cerebral involvement. It is concluded that treatment with trimethoprim-sulfamethoxazole was significantly superior to that with tetracycline in inducing clinical remission of Whipple's disease. A more active antimicrobial regimen is necessary to treat cerebral involvement.Keywords
This publication has 26 references indexed in Scilit:
- Short-Term Antibiotic Treatment in Whipple’s DiseaseJournal of Clinical Gastroenterology, 1991
- Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazoleJournal of Antimicrobial Chemotherapy, 1983
- Cerebral Whipple's Disease with Negative Jejunal HistologyNew England Journal of Medicine, 1979
- The penetration of antibiotics into cerebrospinal fluid and brain tissueJournal of Antimicrobial Chemotherapy, 1978
- Whipple's DiseaseActa Medica Scandinavica, 1978
- Whipple's disease confined to the brain: a case studied clinically and pathologicallyJournal of Neurology, Neurosurgery & Psychiatry, 1977
- NEUROLOGIC DISEASE IN PATIENTS WITH TREATED WHIPPLEʼS DISEASEMedicine, 1976
- Treatment of Whipple's Disease with Sulphamethoxazole‐TrimethoprimActa Medica Scandinavica, 1975
- WHIPPLEʼS DISEASEMedicine, 1970
- Intestinal lipodystrophy (Whipple's disease); the immediate and prolonged effect of antibiotic therapyJAMA, 1966